Ver esta página en español →

Comments Open Now, Through September 14, 2026

This rule could cut your care in half

A new rule could mean an extra doctor’s visit instead of one. Right now, if you have a spot that needs treatment, like a biopsy, your dermatologist can usually treat it the same day they find it. That’s normal. It’s how skin cancer gets caught early. This new rule could get in the way of that. You can tell Medicare how it would affect you. Comments are open now through September 14, 2026.

comments sent so far, and counting
days left to speak up, closes Sept 14 at 11:59 PM

What This Rule Would Change

This rule affects dermatology more than most other kinds of care. Here’s why: when your doctor finds a spot that worries them, they often treat it that same day. That’s normal. It’s the best way to catch skin cancer early. If this rule goes through, some doctors may need to ask you to come back for a second visit instead. That means a second copay. Another day off work. Another ride to arrange. More time spent waiting and worrying about something that could have been treated right away.

Here’s why this could happen. Medicare is run by an agency called CMS. Right now, when you see a doctor and get treated the same day, like with a skin biopsy, Medicare pays in full for both the visit and the treatment. Under the new rule, Medicare would pay in full for only one of the two. It would pay just half price for the other, which is why some practices may feel they have to split a visit in two.

This isn’t just about Medicare. Many other health insurance companies copy Medicare’s rules within a year or two. So this change could affect your insurance too, even if you’re not on Medicare.

This page was made by LIDS to help you write your own comment. We don’t send anything for you. We are not part of CMS or Regulations.gov.

Rule
CY 2027 Medicare Physician Fee Schedule Proposed Rule
File code
CMS-1848-P
Docket
CMS-2026-2377
Comment period closes
September 14, 2026, 11:59 PM ET
Where to read it
Full text on Regulations.gov →
CMS fact sheet
CMS.gov summary →
For your practice
Print a waiting-room flyer →

Build your comment

This tool helps you put your own comment into words. It doesn’t file anything for you — the last step hands you a ready-to-paste comment and a link to Regulations.gov, where you submit it yourself, in your own name.

Use your own words. Regulators tend to group and count identical form-letter comments as one, while a specific, personal comment carries real weight — and federal rules require that a comment be filed by the person it’s actually from, not submitted in bulk on someone’s behalf. The checklist below is there to help if you’re not sure what to say; even one added sentence in your own words makes your comment count more.
Who you are
Your comment
Review & submit
I am…

Also called things like incision and drainage (I&D), cryotherapy, electrodesiccation and curettage (ED&C), or excision — pick whichever is closest to what happened.

Checking a box above adds a starter sentence here. Edit it, delete it, or add your own. A blank form-letter comment doesn’t carry weight; a few sentences that sound like you do.

Regulations.gov comments are public record, so don’t include private patient information.

Regulations.gov will also ask for your name when you submit — this just adds it to the letter itself, which reads as more genuinely yours with one attached. Leave it blank to stay unsigned here.

Your comment

What you’ll see next

The real Regulations.gov page you'll land on, with the blue Comment button highlighted near the top left, below the rule's title

That’s the real page — look for the blue “Comment” button (circled above), just below the rule’s title. Click it, paste your comment in, and submit.

This copies your comment and opens the official Regulations.gov form in a new tab — paste it in and submit. That submission is yours, filed under your own name, not ours. Reference file code CMS-1848-P if asked.